https://ir.biorestorative.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_f07b0c423e1f798e1a3146db853c2d2b/biorestorative/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.biorestorative.com/news-events/press-releases/detail/247/biorestorative-therapies-announces-completion-of-brtx-100-phase-2-manufacturing-highlighting-integrated-regenerative-biologics-platform Thu, 25 Jun 26 08:15:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/247/biorestorative-therapies-announces-completion-of-brtx-100-phase-2-manufacturing-highlighting-integrated-regenerative-biologics-platform https://ir.biorestorative.com/news-events/press-releases/detail/246/biorestorative-therapies-strengthens-leadership-with-appointment-of-healthcare-executive-zachary-smith-as-vice-president-of-biocosmeceuticals-division-to-accelerate-commercial-expansion-and-strategic-growth Thu, 18 Jun 26 08:15:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/246/biorestorative-therapies-strengthens-leadership-with-appointment-of-healthcare-executive-zachary-smith-as-vice-president-of-biocosmeceuticals-division-to-accelerate-commercial-expansion-and-strategic-growth https://ir.biorestorative.com/news-events/press-releases/detail/245/biorestorative-completes-phase-2-dosing-of-brtx-100-advancing-lead-regenerative-spine-program-toward-2027-topline-data Tue, 26 May 26 11:00:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/245/biorestorative-completes-phase-2-dosing-of-brtx-100-advancing-lead-regenerative-spine-program-toward-2027-topline-data https://ir.biorestorative.com/news-events/press-releases/detail/244/biorestorative-therapies-presents-new-preclinical-data-at-isct-2026-highlighting-source-specific-exosome-functionality-and-commercial-applications-in-biocosmeceuticals Wed, 13 May 26 11:00:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/244/biorestorative-therapies-presents-new-preclinical-data-at-isct-2026-highlighting-source-specific-exosome-functionality-and-commercial-applications-in-biocosmeceuticals https://ir.biorestorative.com/news-events/press-releases/detail/243/biorestorative-therapies-reports-expanded-phase-2-blinded-dataset-for-brtx-100-showing-sustained-pain-and-functional-improvements-in-chronic-lumbar-disc-disease Thu, 07 May 26 12:00:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/243/biorestorative-therapies-reports-expanded-phase-2-blinded-dataset-for-brtx-100-showing-sustained-pain-and-functional-improvements-in-chronic-lumbar-disc-disease https://ir.biorestorative.com/news-events/press-releases/detail/242/biorestorative-therapies-to-present-new-data-at-isct-2026-highlighting-its-ongoing-phase-2-clinical-trial-in-chronic-lumbar-disease-and-its-biocosmeceutical-platform Thu, 30 Apr 26 10:36:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/242/biorestorative-therapies-to-present-new-data-at-isct-2026-highlighting-its-ongoing-phase-2-clinical-trial-in-chronic-lumbar-disease-and-its-biocosmeceutical-platform https://ir.biorestorative.com/news-events/press-releases/detail/241/biorestorative-therapies-announces-strategic-partnership-with-global-dermatology-leader-dr-david-j-goldberg-to-lead-clinical-evaluation-and-seek-multi-channel-adoption-of-its-regenerative-biocosmeceutical-platform Tue, 21 Apr 26 08:00:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/241/biorestorative-therapies-announces-strategic-partnership-with-global-dermatology-leader-dr-david-j-goldberg-to-lead-clinical-evaluation-and-seek-multi-channel-adoption-of-its-regenerative-biocosmeceutical-platform https://ir.biorestorative.com/news-events/press-releases/detail/240/biorestorative-therapies-announces-strategic-collaboration-with-203-creates-to-build-and-commercialize-biocosmeceutical-platform Tue, 07 Apr 26 08:15:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/240/biorestorative-therapies-announces-strategic-collaboration-with-203-creates-to-build-and-commercialize-biocosmeceutical-platform https://ir.biorestorative.com/news-events/press-releases/detail/239/biorestorative-therapies-reports-positive-phase-2-blinded-data-for-brtx-100-demonstrating-meaningful-improvements-in-pain-and-function-in-chronic-lumbar-disc-disease Mon, 30 Mar 26 08:00:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/239/biorestorative-therapies-reports-positive-phase-2-blinded-data-for-brtx-100-demonstrating-meaningful-improvements-in-pain-and-function-in-chronic-lumbar-disc-disease https://ir.biorestorative.com/news-events/press-releases/detail/238/biorestorative-therapies-to-present-positive-phase-2-blinded-data-for-brtx-100-demonstrating-meaningful-improvements-in-pain-and-function-in-chronic-lumbar-disc-disease Thu, 19 Mar 26 08:00:00 -0400 https://ir.biorestorative.com/news-events/press-releases/detail/238/biorestorative-therapies-to-present-positive-phase-2-blinded-data-for-brtx-100-demonstrating-meaningful-improvements-in-pain-and-function-in-chronic-lumbar-disc-disease